SHOP CANNABIS

Highs: Reduced CBD content for category. Good aid /w Pain**. Bargain priced. Good brand rating.

Lows: No product specific written reviews available.

About Tropical Gelato Slushie

A bargain priced hybrid strain dried flower at $4.52/g, hybrid-greenhouse grown in Ontario by Tweed in the Cannabis Flower category with 27% Medium THC potency and 0.5% Nominal CBD content.

Using available terpene and strain data, we find Tropical Gelato Slushie to have:

• a predominant sweet aroma including mix of woody and citrus,
• a 5/10 score for aid with pain** including help with anxiety and arthritis,

On-Label flavours:  tropical,  citrus.

Highs include: Reduced CBD content for category; Good aid /w Pain**; Bargain priced; Good brand rating. Noted observations: No product specific written reviews available.

About Tweed

Hi. We're Tweed, Canada's leading source for all things cannabis. For us, it’s about more than just growing seeds into plants. It’s about starting a conversation and opening minds to fresh perspectives. And, perhaps most of all, it’s about becoming a part of the fabric of every neighbourhood that welcomes us.

We have a wide selection of products that are as diverse as the communities we serve. We're constantly working to refine well-known strains from around the world, while also breeding proprietary genetics. With a commitment to best-in-class customer service, strain variety, and quality assurance, Tweed is setting the new standard for cannabis, right here in Canada.

About Canopy Growth

Our vision is to be the number one cannabis company in the world. From product and process innovation to market execution and everything in between, we are driven by a passion for leadership, a commitment to drive the industry forward, and above all else, providing medical and recreational cannabis consumers the best possible experience.

With operations spanning fifteen countries across five continents, Canopy Growth Corporation is a world-leading diversified cannabis company proudly dedicated to educating healthcare practitioners, advancing the public discourse surrounding cannabis, and conducting robust clinical research in cannabinoid-based animal and human medicines.